X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2026)

X4 Pharmaceuticals (XFOR) has reported Tax Provisions for 7 consecutive years, with $2000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions fell 94.59% year-over-year to $2000.0; the trailing twelve-month figure through Jun 2026 stood at -$28000.0 (down 108.14% YoY), and the FY2025 full-year result was $41000.0, down 86.77% from the prior year.
• Tax Provisions grew to $2000.0 in Q2 2026 per XFOR's latest filing, from -$30000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $258000.0 in Q4 2024 and bottomed at -$30000.0 in Q3 2025.
• Historically, Tax Provisions has averaged $28687.5 across 5 years, with a median of $16500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 750.0% in 2022, then soared 681.82% in 2024.
• Over 5 years, Tax Provisions stood at $14000.0 in 2022, then jumped by 135.71% to $33000.0 in 2023, then jumped by 681.82% to $258000.0 in 2024, then tumbled by 111.63% to -$30000.0 in 2025, then soared by 106.67% to $2000.0 in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $2000.0, -$30000.0, and $37000.0 for Q2 2026, Q3 2025, and Q2 2025 respectively.